TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01082900

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic CPAP Administration
Description: EXPERIMENTAL GROUP: Babies will receive prophylactic administration of CPAP (5 cm of H2O) in the Delivery Room via T piece (Neopuff)~CONTROL GROUP: Provision of standard care in the Delivery Room

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prophylactic CPAP Administration
Description: EXPERIMENTAL GROUP: Babies will receive prophylactic administration of CPAP (5 cm of H2O) in the Delivery Room via T piece (Neopuff)~CONTROL GROUP: Provision of standard care in the Delivery Room
Study: NCT03665532

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Engagement in Services
Description: Brief phone coaching to enhance engagement, retention, and sustain adherence to HIV and substance use services for younger people living with HIV.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Youth Engagement in Services
Description: Brief phone coaching to enhance engagement, retention, and sustain adherence to HIV and substance use services for younger people living with HIV.
Study: NCT02808182

Intervention type: DRUG
Group type: OTHER
Intervention: Nicotinic acid
Description: oral administration of nicotinic acid (100mg at 0, 30, 60, 90, 120, 180, 240 and 300 min) to minimize WAT intracellular lipolysis

Intervention type: DRUG
Group type: OTHER
Intervention: Nicotinic acid
Description: oral administration of nicotinic acid (100mg at 0, 30, 60, 90, 120, 180, 240 and 300 min) to minimize WAT intracellular lipolysis

Intervention type: OTHER
Group type: OTHER
Intervention: [7,7,8,8-2H]-palmitate
Description: using i.v. administration of \[7,7,8,8-2H\]-palmitate (in 25% human albumin) from time -60 to +360 min

Intervention type: OTHER
Group type: OTHER
Intervention: [7,7,8,8-2H]-palmitate
Description: using i.v. administration of \[7,7,8,8-2H\]-palmitate (in 25% human albumin) from time -60 to +360 min

Intervention type: OTHER
Group type: OTHER
Intervention: [U-13C]-palmitate
Description: oral administration of \[U-13C\]-palmitate (0.2 g mixed into the liquid meal) at time 0 min

Intervention type: OTHER
Group type: OTHER
Intervention: [U-13C]-palmitate
Description: oral administration of \[U-13C\]-palmitate (0.2 g mixed into the liquid meal) at time 0 min

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Biopsy
Description: A subcutaneous abdominal 0.5-g adipose tissue biopsy will be performed at the end of protocols A0 and A1

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Biopsy
Description: A subcutaneous abdominal 0.5-g adipose tissue biopsy will be performed at the end of protocols A0 and A1

Intervention type: OTHER
Group type: OTHER
Intervention: liquid meal
Description: At time 0, a standard liquid meal (400 mL, 906 kcal, 33g-fat/34g-protein/101g-carbohydrates i.e. 33%/17%/50% calories) will be drunk over 20 minutes

Intervention type: OTHER
Group type: OTHER
Intervention: liquid meal
Description: At time 0, a standard liquid meal (400 mL, 906 kcal, 33g-fat/34g-protein/101g-carbohydrates i.e. 33%/17%/50% calories) will be drunk over 20 minutes
Study: NCT06778369

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: traingular exclusion technique in mitral valve repair
Description: The prolapsed part of the posterior leaflet is inverted and excluded, not resected toward the left ventricle, and the margins of the prolapsed part are sutured to each other's using proline 5/0, extending from the posterior leaflet edge to the posterior annulus. Then the posterior annulus is reinforced with an annuloplasty band using a treated strip of pericardium. The determination of suitable ring size is subsequently predicated upon the assessment of inter-commissural distance surface area and the anterior leaflet, utilizing sizers that are correlated with typical mitral geometry.
Study: NCT04201691

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: classic rehabilitation
Description: The intervention is conventional rehabilitation that included streching, balance and coordination training. The intervention is applied to participants, manually.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: classic rehabilitation
Description: The intervention is conventional rehabilitation that included streching, balance and coordination training. The intervention is applied to participants, manually.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: classic rehabilitation+mobilization
Description: Another intervention is manuel therapy that included gliding technics, rotational technics at cervical region. (in addition to classic rehabilitation). The intervention is applied to participants, manually.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: classic rehabilitation+mobilization
Description: Another intervention is manuel therapy that included gliding technics, rotational technics at cervical region. (in addition to classic rehabilitation). The intervention is applied to participants, manually.
Study: NCT00186446

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bupropion and smoking cessation behavioral intervention
Study: NCT01898754

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-ART Oligonucleotide Assay (OLA)
Description: Block randomization (1:1) to pre-ART OLA testing or OLA testing after 12mo on ART
Study: NCT03777566

Intervention type: DIAGNOSTIC_TEST
Intervention: sonohysterography
Description: sonohysterography with measuring the uterine cavity volume

Intervention type: DIAGNOSTIC_TEST
Intervention: sonohysterography
Description: sonohysterography with measuring the uterine cavity volume
Study: NCT04876495

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey protein isolate
Description: Instantized BiPRO® 50g (equiv. 45.5g of total protein) presented to participants in a form of a shake.~Other ingredients in the whey protein shake:~* Tropicana Trop50 Orange Juice 207mL~* Water 43 mL~* Sucralose 0.5g~The total energy 233.47Kcal.~Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Potato protein isolate
Description: Solanic®100 48g (equiv. 45.3g of total protein) presented to participants in a form of a shake.~Other ingredients in the potato protein shake:~* Tropicana Trop50 Orange Juice 250mL~* Sucralose 0.5g~The total energy 233.46Kcal~Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rice protein isolate
Description: Oryzatein® Silk 90 50g (equiv. 45.5g of total protein) presented to participants in a form of a shake.~Other ingredients in the rice protein shake:~* Tropicana Trop50 Orange Juice 183mL~* Water 67mL~* Sucralose 0.5g~The total energy 233.43Kcal~Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.
Study: NCT04688905

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive hemodynamics of left ventricle via conductance catheter at rest, with exercise and with temporary vena cava occlusion
Description: Invasive hemodynamics of left ventricle will be done by the conductance method. Left ventricular stiffness constant will be obtained by temporary vena cava occlusion. Right heart catherization will be done by pulmonary artery catherization and cardiac output will be estimated by thermodilution and Fick´s method.

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive hemodynamics of left ventricle via conductance catheter at rest, with exercise and with temporary vena cava occlusion
Description: Invasive hemodynamics of left ventricle will be done by the conductance method. Left ventricular stiffness constant will be obtained by temporary vena cava occlusion. Right heart catherization will be done by pulmonary artery catherization and cardiac output will be estimated by thermodilution and Fick´s method.
Study: NCT02195999

Intervention type: OTHER
Intervention: Magnetic Resonance Imaging (MRI)
Description: It is a non-invasive method to determine ventricular size, volumes, mass, and ejection fraction.

Intervention type: OTHER
Intervention: Pulmonary Function Testing (PFT)
Description: It is non-invasive breathing tests that characterize respiratory muscle function, as well as lung compliance and physiology.

Intervention type: OTHER
Intervention: Metabolic Exercise Testing using stationary bicycle
Description: Metabolic exercise testing, including assessment of exercise capacity and MVO2, evaluates global cardiopulmonary functional status. This is performed with the use of a stationary bicycle.

Intervention type: OTHER
Intervention: Echocardiogram
Description: The echocardiogram performed with the multiple-echo Dixon method helps to assess participants cross-sectionally and longitudinally for variations and changes in myocardial structure.
Study: NCT02680041

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-fluciclovine PET CT
Description: Subjects will undergo a fluciclovine F18 PET/CT scan in addition to standard of care monitoring. The results of this scan may influence further treatment
Study: NCT01819610

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPRIX
Study: NCT05667675

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Support Worker
Description: Participants in the intervention group will have a structured review of their financially related needs and resources with a trained CSW, who will have a thorough understanding of potential income supports and community support agencies. The CSW will use a structured approach to identify financial needs and benefits for which the family is eligible The CSW will work intensively with families in the intervention arm to identify and meet their goals. They will conduct weekly meetings to complete forms, and provide advocacy (in person and by telephone) as needed up to six meetings as needed for system navigation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: There is no clear standard of care and potential for practice variation in clinician responses to identified social need. For this proposal, participants in the comparator group will receive Usual care, defined as: Participants in both groups will receive a written summary of available resources.
Study: NCT01871571

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bevacizumab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leucovorin calcium
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluorouracil
Description: Given IV
Study: NCT00958321

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: computed tomography

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-dimensional conformal radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: fludeoxyglucose F 18

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy treatment planning/simulation
Study: NCT04125901

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education and Exercise
Description: The incorporation of the exercise in this group will be gradual, in order to decrease the education component and increase the exercise component (up to 45/60 minutes). The 1st session will be only PNE and will last approximately 45 minutes. In the 2nd session, there will be 30 minutes of PNE and the remaining 15 minutes of exercise. In the following 4th and 6th sessions, 15 minutes of each session will be used to clarify doubts and emphasize PNE concepts and strategies. The 8th session will include exercises only. In WhatsApp sessions, in addition to the video with the exercises, participants will receive activities about the PNE.

Intervention type: OTHER
Group type: OTHER
Intervention: Exercise
Description: The exercise group will perform exercises in all sessions (45 minutes of exercise in face-to-face sessions). In WhatsApp sessions, participants will receive a video with exercises to perform at home.
Study: NCT03110536

Intervention type: DIAGNOSTIC_TEST
Intervention: Copenhagen Burnout Inventory
Description: A questionnaire based on Copenhagen Burnout Inventory will be completed by each participant to the study, at the beginning of the triage shift and after 2, 4 or 6 hours.~The questionnaire also contains clinical cases that require triage coding.
Study: NCT03584841

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Iontophoresis sessions in forearm of subjects with pilocarpine
Description: The test with two iontophoresis sessions is performed in a forearm of subjects. Pilocarpine is applied during the first iontophoresis session to evoke cholinergic-induced sweat secretion. Atropine, isoprenaline and aminophylline are applied during the second iontophoresis session, to block the cholinergic component and to evoke β-adrenergic-induced sweat secretion.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Iontophoresis sessions in forearm of subjects with pilocarpine
Description: The test with two iontophoresis sessions is performed in a forearm of subjects. Pilocarpine is applied during the first iontophoresis session to evoke cholinergic-induced sweat secretion. Atropine, isoprenaline and aminophylline are applied during the second iontophoresis session, to block the cholinergic component and to evoke β-adrenergic-induced sweat secretion.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Iontophoresis sessions in forearm of subjects with pilocarpine
Description: The test with two iontophoresis sessions is performed in a forearm of subjects. Pilocarpine is applied during the first iontophoresis session to evoke cholinergic-induced sweat secretion. Atropine, isoprenaline and aminophylline are applied during the second iontophoresis session, to block the cholinergic component and to evoke β-adrenergic-induced sweat secretion.
Study: NCT01711489

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: isavuconazole
Description: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Description: oral
Study: NCT03441867

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Seizures
Description: CBT-informed psychotherapy for patients with PNES and PTE

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Seizures
Description: CBT-informed psychotherapy for patients with PNES and PTE

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Medical Care
Description: Observational - standard medical care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Medical Care
Description: Observational - standard medical care
Study: NCT03110536

Intervention type: DIAGNOSTIC_TEST
Intervention: Copenhagen Burnout Inventory
Description: A questionnaire based on Copenhagen Burnout Inventory will be completed by each participant to the study, at the beginning of the triage shift and after 2, 4 or 6 hours.~The questionnaire also contains clinical cases that require triage coding.

Intervention type: DIAGNOSTIC_TEST
Intervention: Copenhagen Burnout Inventory
Description: A questionnaire based on Copenhagen Burnout Inventory will be completed by each participant to the study, at the beginning of the triage shift and after 2, 4 or 6 hours.~The questionnaire also contains clinical cases that require triage coding.
Study: NCT00391430

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sertraline
Description: Dosage: up to 100 mg/day; Frequency: once per day; Duration: 12 weeks

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Description: CBT consists of sixteen 1-hour sessions during a period of 12 weeks.
Study: NCT00776672

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fosinopril 40mg Tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fosinopril 40mg Tablets
Study: NCT01858142

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parental presence decision tool

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard preparation
Study: NCT02168049

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Integrated CardioRespiratory System
Description: Participants will be asked to wear a non-invasive band on their upper abdomen while laying down. This band includes acoustic sensors. A remote monitoring device will continuously monitor and record heart rate and lung volumes and function.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transthoracic Echocardiography (TTE)
Description: Participants will undergo a TTE examination. During the TTE, a technician obtains views of the heart by moving a small instrument called a transducer to different locations on the chest or abdominal wall.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrocardiography
Description: Participants will also have ECG monitoring as part of the TTE exam, which records the electrical activity of the heart using electrodes placed on the body.
Study: NCT02584543

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HEV vaccine

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: HEV vaccine

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: HBV vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HBV vaccine
Study: NCT02390440

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EXPAREL
Study: NCT03807791

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: A blood sample will be taken by the nurse of our unit within a week after their consent. It consists as a simple blood sample and it will be taken during the normal analysis planed by the chief of the service in order to avoid to collect two different samples.~The measurement method will use equipment from the Lyon Sud hospital laboratory. The samples need a pre-treatment in the 3 hours after taking the blood to avoid the oxidation of vitamin C and a result lower than expected.
Study: NCT00145184

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multivitamin supplement containing vitamins B, C, and E
Description: A daily oral dose of between 1.5 to 3 times the age- appropriate Recommended Dietary Allowance (RDA) of each vitamin taken for two months starting at enrollment.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill taken orally once per day for two months starting at enrollment.
Study: NCT01317576

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Subjects will be training for 12 week, 3 times a week. Two times a week they will perform a 30 minutes bicycle training. Once a week they will perform a 30 minutes resistance training.
Study: NCT03110536

Intervention type: OTHER
Intervention: Triage scoring efficacy
Description: The triage scores of the first 5 and the last 5 cases assessed by the investigated nurse will be compared with the triage codes of an expert evaluator (nurse involved in designing The National triage Protocol).

Intervention type: OTHER
Intervention: Triage scoring efficacy
Description: The triage scores of the first 5 and the last 5 cases assessed by the investigated nurse will be compared with the triage codes of an expert evaluator (nurse involved in designing The National triage Protocol).

Intervention type: OTHER
Intervention: Triage scoring efficacy
Description: The triage scores of the first 5 and the last 5 cases assessed by the investigated nurse will be compared with the triage codes of an expert evaluator (nurse involved in designing The National triage Protocol).
Study: NCT01317576

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Subjects will be training for 12 week, 3 times a week. Two times a week they will perform a 30 minutes bicycle training. Once a week they will perform a 30 minutes resistance training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Subjects will be training for 12 week, 3 times a week. Two times a week they will perform a 30 minutes bicycle training. Once a week they will perform a 30 minutes resistance training.
Study: NCT02243618

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polaprezinc
Description: Administration of pantoprazole 40 mg q.d. and polaprezinc 75 mg b.i.d. for 4 weeks after the ESD.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rebamipide
Description: Administration of pantoprazole 40 mg q.d. and rebamipide 100 mg t.i.d. for 4 weeks after the ESD.
Study: NCT00665054

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levitra (Vardenafil, BAY38-9456)
Description: 5, 10, or 20 mg Vardenafil tablets orally prior to sexual activity

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo tablets orally prior to sexual activity
Study: NCT04331184

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: RFA using combined bipolar and monopolar energy deliver
Description: RFA technique combining bipolar mode and switching monopolar mode using dual / Twin Cooled-wet electrodes is performed on residual tumors after transarterial chemo-embolization.
Study: NCT01907321

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training
Description: Small hand held device that provides calibrated (cmH20) resistance to expiratory pressure. Once sufficient pressure is achieved (participant blowing out into the device) a valve is released, letting air flow through.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo expiratory training
Description: Device with the same look and feel as the active EMST, but which provides no resistance to airflow.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Measures performed on all subjects
Description: Capsaicin is a cough-inducing vapor that will be inhaled by participants to induce coughing. The airflow of the cough will be recorded and measures of compression phase duration, peak expiratory flow rate, and post-peak plateau phase will be made.
Study: NCT03170882

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib
Description: Ixazomib capsules

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pomalidomide
Description: Pomalidomide capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone tablets